Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins

18 Jan 2011

Abstract excerpt

Adeno-associated virus vectors (AAV) show promise for liver-targeted gene therapy. In this study, we examined the long-term consequences of a single intravenous administration of a self-complementary AAV vector (scAAV2/ 8-LP1-hFIXco) encoding a codon optimized human factor IX (hFIX) gene in 24 nonhuman primates (NHPs). A dose-response relationship between vector titer and transgene expression was observed. Peak...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Viral gastroenteritis research and epidemiology
Share to Viral Infectious Diseases and Gene Expression in Insects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Virus-based gene therapy research

Source

Identifiers

PMID: 21245849
DOI: 10.1038/mt.2010.274

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid ProteinsPMID 21245849Read ↗

Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primatesSemantic proximity Read ↗

Optimization of Self-complementary AAV Vectors for Liver-directed Expression Results in Sustained Correction of Hemophilia B at Low Vector DoseSemantic proximity Read ↗

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaquesSemantic proximity Read ↗

Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors.Semantic proximity Read ↗

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia BSemantic proximity Read ↗

Adeno-associated virus-based gene therapy for hemophilia–addressing the gapsSemantic proximity Read ↗

Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia ASemantic proximity Read ↗

Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia ASemantic proximity Read ↗

Gene therapy for the hemophilias.Semantic proximity Read ↗

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia ASemantic proximity Read ↗

Adeno-Associated Virus Gene Therapy for Liver DiseaseSemantic proximity Read ↗

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.